Walter van der Vliet on LinkedIn: #ngs #sarscov2 #rcpcr
Por um escritor misterioso
Descrição
Walter Rogal - Clinical Safety Manager - University of Pennsylvania School of Medicine
Walter Rogal - Clinical Safety Manager - University of Pennsylvania School of Medicine
Walter van der Vliet - Application Scientist - Oxford Nanopore Technologies
Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity, QRB Discovery
Walter van der Vliet on LinkedIn: #ngs #sarscov2 #rcpcr #epidemiology #virology #sequencing #covid19
Colinda van der Zeeuw heeft een bijdrage op LinkedIn geplaatst
Walter Rollins - Chief Development Officer - Nexus VBC Partners
R&D Team Manager ProQR Therapeutics
Virtual Polymer Compounds
Erich Walter - Research Scientist - SPAWAR
Wastewater Surveillance for SARS-CoV-2 RNA in Canada
Greg Vander Wal - Solutions Architect - Gentex Corporation
de
por adulto (o preço varia de acordo com o tamanho do grupo)
